Skip to content

US · BEATW · MEDICAL - HEALTHCARE INFORMATION SERVICES

HeartBeam, Inc. (BEATW) intrinsic value and stock valuation

$0.01as of 2026-11-21 · Mkt cap 14.32M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

HeartBeam, Inc. DCF and intrinsic value

InvestorsCraft values BEATW with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from BEATW’s statements →

HeartBeam, Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Healthcare Information Services Santa Clara, CA 95050 heartbeam.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$0.00
20112025
Net income
-$-21.02M
20112025
Free cash flow
-$-14.59M
20112025
Total equity
$2.6M
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$0.00$0.00$0.00$0.00$0.00
Operating income-$-21.14M-$-19.89M-$-15.31M-$-13.03M-$-2.29M
Net income-$-21.02M-$-19.45M-$-14.64M-$-12.96M-$-4.43M
EPSd-$-623.55K-$-729.83K-$-720.12K-$-1.59M-$-567.22K
Operating cash flow-$-13.99M-$-14.47M-$-12.09M-$-9.95M-$-3.23M
Capital expenditure-$-600K-$-200K-$-260K$0.00$0.00
Free cash flow-$-14.59M-$-14.67M-$-12.35M-$-9.95M-$-3.23M
Total assets$5.84M$3.28M$17.1M$4.04M$14M
Total debt$0.00$0.00$0.00$0.00$0.00
Net debt-$-4.38M-$-2.38M-$-16.19M-$-3.59M-$-13.19M
Total equity$2.6M$1.65M$15.9M$2.37M$13.4M
Cash and short-term investments$4.38M$2.38M$16.2M$3.59M$13.2M
Income statement
20252024202320222021
Revenue$0.00$0.00$0.00$0.00$0.00
Cost of revenue$0.00$0.00$0.00$0.00$0.00
Gross profit$0.00$0.00$0.00$0.00$0.00
Research and development expenses$13.5M$11.1M$6.8M$5.68M$260K
Selling, general and administrative expenses$7.69M$8.84M$8.52M$7.35M$2.03M
Other expenses$0.00$0.00$0.00$0.00$0.00
Operating expenses$21.1M$19.9M$15.3M$13M$2.29M
Cost and expenses$21.1M$19.9M$15.3M$13M$2.29M
Interest income$120K$450K$680K$70K$0.00
Interest expense$0.00$0.00$0.00$70K$2.17M
Depreciation and amortization$40K$10K$15.3M$13M$0.00
Ebitda-$-20.98M-$-19.44M$680K$70K-$-2.26M
Operating income-$-21.14M-$-19.89M-$-15.31M-$-13.03M-$-2.29M
Total other income/expenses, net$120K$440K$680K$70K-$-2.14M
Income before tax-$-21.02M-$-19.45M-$-14.64M-$-12.96M-$-4.43M
Income tax expense$0.00$0.00$0.00$0.00$0.00
Net income-$-21.02M-$-19.45M-$-14.64M-$-12.96M-$-4.43M
Weighted average shares outstanding$33.7M$26.7M$20.3M$8.17M$7.81M
Weighted average diluted shares outstanding$33.7M$26.7M$20.3M$8.17M$7.81M
Balance sheet
20252024202320222021
Cash and short-term investments$4.38M$2.38M$16.2M$3.59M$13.2M
Net receivables$0.00$0.00$0.00$0.00$0.00
Inventory$100K$0.00$0.00$0.00$0.00
Total current assets$4.68M$2.77M$16.8M$4.04M$14M
Property, plant and equipment, net$1.1M$450K$260K$0.00$0.00
Goodwill and intangible assets$0.00$0.00$0.00$0.00$0.00
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$1.16M$510K$310K$0.00$810K
Total assets$5.84M$3.28M$17.1M$4.04M$14M
Accounts payable$1.05M$530K$560K$1.66M$590K
Short-term debt$0.00$0.00$0.00$0.00$0.00
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$3.24M$1.62M$1.19M$1.67M$590K
Long-term debt$0.00$0.00$0.00$0.00$0.00
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$0.00$0.00$0.00$0.00$0.00
Capital lease obligations$0.00$0.00$0.00$0.00$0.00
Total liabilities$3.24M$1.62M$1.19M$1.67M$590K
Common stock$0.00$0.00$0.00$0.00$0.00
Retained earnings-$-77.29M-$-56.27M-$-36.83M-$-22.19M-$-9.22M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00$0.00
Total equity$2.6M$1.65M$15.9M$2.37M$13.4M
Total investments$0.00$0.00$0.00$0.00$0.00
Total debt$0.00$0.00$0.00$0.00$0.00
Net debt-$-4.38M-$-2.38M-$-16.19M-$-3.59M-$-13.19M
Cash flow statement
20252024202320222021
Net income-$-21.02M-$-19.45M-$-14.64M-$-12.96M-$-4.43M
Depreciation and amortization$40K$10K$0.00$0.00$0.00
Stock-based compensation$5.15M$4.3M$3.21M$1.12M$190K
Change in working capital$1.61M$670K-$-660K$1.89M-$-1.14M
Accounts receivable$0.00$0.00$0.00$0.00$0.00
Inventory-$-100K$0.00$0.00$0.00$0.00
Accounts payable$0.00$430K-$-470K$1.53M$0.00
Net cash provided by operating activities-$-13.99M-$-14.47M-$-12.09M-$-9.95M-$-3.23M
Investments in property, plant and equipment-$-600K-$-200K-$-260K$0.00$0.00
Acquisitions, net$0.00$0.00$0.00$0.00$0.00
Net cash used for investing activities-$-600K-$-200K-$-260K$0.00$0.00
Common stock issued$16.6M$730K$25M$350K$14.7M
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$16.6M$870K$25M$350K$16.4M
Net change in cash$2M-$-13.81M$12.6M-$-9.6M$13.2M
Cash at end of period$4.44M$2.43M$16.2M$3.59M$13.2M
Operating cash flow-$-13.99M-$-14.47M-$-12.09M-$-9.95M-$-3.23M
Capital expenditure-$-600K-$-200K-$-260K$0.00$0.00
Free cash flow-$-14.59M-$-14.67M-$-12.35M-$-9.95M-$-3.23M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About HeartBeam, Inc.

        HeartBeam, Inc. is an emerging enterprise concentrating on innovative cardiovascular diagnostic technology. The company has developed an electrocardiogram (ECG) collection device specifically designed to gather critical heart health data from patients remotely. This system enables medical professionals to access vital diagnostic insights even when the patient is outside a traditional clinical setting. ECG readings are transmitted wirelessly from the device to a patient's smartphone, which then relays this information to a sophisticated, cloud-based expert software system for analysis. Branislav Vajdic established this Santa Clara, California-headquartered company in 2015.

        CEO
        Branislav Vajdic
        Employees
        16
        Beta
        0.89

        Explore

        Frequently asked questions

        What is the intrinsic value of HeartBeam, Inc. (BEATW)?

        InvestorsCraft does not currently publish an intrinsic value for BEATW. How the IC value is calculated.

        Is BEATW undervalued?

        InvestorsCraft does not publish an undervaluation signal for BEATW at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.